Benefits of short daily home hemodialysis in the FREEDOM Study: is it about person, place, time, or treatment?
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 22892857.
- Also identified by DOI 10.1038/ki.2012.161.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Many end-stage renal disease patients receive thrice-weekly hemodialysis (HD) and report impairments in health-related quality of life (HRQOL). Recent studies indicate that short daily HD may improve HRQOL. High-quality studies exploring the burdens and costs to patients, caregivers, and society are necessary before widespread adoption can be advocated. Further research exploring the mechanisms by which these benefits are realized is also important, as many patients are likely to opt out of short daily HD.
Medical subject headings
- Health Status
- Hemodialysis, Home
- Kidney Failure, Chronic
- Quality of Life